The histopathologic features of 10 myxoid adrenocortical neoplasms were analyzed, and epidermal growth factor receptor (EGFR) expression, EGFR gene copy number, and EGFR gene mutations in the 10 tumors were detected by using immunohistochemical analysis, fluorescence in situ hybridization, and the Scorpion Amplification Refractory Mutation System (DxS, Manchester, England), respectively. Histologically, all 10 tumors varied in their myxoid composition, ranging from 20 % to 95%. EGFR protein overexpression was more frequent in myxoid adrenocortical carcinomas (3/4) than in myxoid adrenocortical adenomas (0/6). However, EGFR mutations and EGFR amplification were rare. All patients with adenomas survived for th
AIMS: The differentiation of adrenocortical carcinomas from adenomas may be difficult based on morph...
Endocrine tumors may be benign or malignant and may occur in any of the hormone producing tissues. T...
The last decade witnessed the emergence of genomics, a set of high-throughput molecular measurements...
Adrenocortical carcinoma (ACC) is a rare disease with a poor prognosis and limited therapeutic optio...
2 Background Adrenocortical carcinoma (ACC) is a rare disease with a poor prognosis and limited ther...
Introdução: Uma elevada incidência de tumores adrenocorticais pediátricos e de adultos é observada n...
International audienceThe aim of this study was to identify predictor sets of genes whose over- or u...
Adrenocortical tumors (ACT) are rare neoplasms of the adrenal glands accounting for 0.2% of all pedi...
Adrenocortical cancer is a rare tumor form. However, adrenal tumors are today often found incidental...
The aim of this study was to investigate the epidermal growth factor receptor (EGFR) status in epend...
Myxoid changes have been rarely reported both in adrenocortical adenomas and carcinomas. The recent ...
BACKGROUND: The progression of normal prostatic epithelium to androgen-dependent cancer and, eventua...
Mammary phyllodes tumors are uncommon stromal-epithelial neoplasms, and are divided into benign, bor...
Objective: In many cases, the prognosis of an adrenocortical tumor cannot be determined from patho-l...
BACKGROUND: Amplification and mutation of the epidermal growth factor receptor (EGFR) and Her-2 gene...
AIMS: The differentiation of adrenocortical carcinomas from adenomas may be difficult based on morph...
Endocrine tumors may be benign or malignant and may occur in any of the hormone producing tissues. T...
The last decade witnessed the emergence of genomics, a set of high-throughput molecular measurements...
Adrenocortical carcinoma (ACC) is a rare disease with a poor prognosis and limited therapeutic optio...
2 Background Adrenocortical carcinoma (ACC) is a rare disease with a poor prognosis and limited ther...
Introdução: Uma elevada incidência de tumores adrenocorticais pediátricos e de adultos é observada n...
International audienceThe aim of this study was to identify predictor sets of genes whose over- or u...
Adrenocortical tumors (ACT) are rare neoplasms of the adrenal glands accounting for 0.2% of all pedi...
Adrenocortical cancer is a rare tumor form. However, adrenal tumors are today often found incidental...
The aim of this study was to investigate the epidermal growth factor receptor (EGFR) status in epend...
Myxoid changes have been rarely reported both in adrenocortical adenomas and carcinomas. The recent ...
BACKGROUND: The progression of normal prostatic epithelium to androgen-dependent cancer and, eventua...
Mammary phyllodes tumors are uncommon stromal-epithelial neoplasms, and are divided into benign, bor...
Objective: In many cases, the prognosis of an adrenocortical tumor cannot be determined from patho-l...
BACKGROUND: Amplification and mutation of the epidermal growth factor receptor (EGFR) and Her-2 gene...
AIMS: The differentiation of adrenocortical carcinomas from adenomas may be difficult based on morph...
Endocrine tumors may be benign or malignant and may occur in any of the hormone producing tissues. T...
The last decade witnessed the emergence of genomics, a set of high-throughput molecular measurements...